JP2022528783A5 - - Google Patents

Info

Publication number
JP2022528783A5
JP2022528783A5 JP2021560711A JP2021560711A JP2022528783A5 JP 2022528783 A5 JP2022528783 A5 JP 2022528783A5 JP 2021560711 A JP2021560711 A JP 2021560711A JP 2021560711 A JP2021560711 A JP 2021560711A JP 2022528783 A5 JP2022528783 A5 JP 2022528783A5
Authority
JP
Japan
Prior art keywords
active ingredient
process space
granules
tablet
ingredient granules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021560711A
Other languages
English (en)
Japanese (ja)
Other versions
JP7602483B2 (ja
JP2022528783A (ja
Filing date
Publication date
Priority claimed from EP19168685.6A external-priority patent/EP3721871A1/de
Application filed filed Critical
Publication of JP2022528783A publication Critical patent/JP2022528783A/ja
Publication of JP2022528783A5 publication Critical patent/JP2022528783A5/ja
Application granted granted Critical
Publication of JP7602483B2 publication Critical patent/JP7602483B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021560711A 2019-04-11 2020-04-09 有効成分顆粒の連続製造のための方法 Active JP7602483B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19168685.6A EP3721871A1 (de) 2019-04-11 2019-04-11 Verfahren zur kontinuierlichen herstellung eines wirkstoffgranulats
EP19168685.6 2019-04-11
PCT/EP2020/060278 WO2020208202A1 (de) 2019-04-11 2020-04-09 Verfahren zur kontinuierlichen herstellung eines wirkstoffgranulats

Publications (3)

Publication Number Publication Date
JP2022528783A JP2022528783A (ja) 2022-06-15
JP2022528783A5 true JP2022528783A5 (enExample) 2023-04-14
JP7602483B2 JP7602483B2 (ja) 2024-12-18

Family

ID=66105207

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021560711A Active JP7602483B2 (ja) 2019-04-11 2020-04-09 有効成分顆粒の連続製造のための方法

Country Status (13)

Country Link
US (1) US12551443B2 (enExample)
EP (2) EP3721871A1 (enExample)
JP (1) JP7602483B2 (enExample)
CN (2) CN114302711A (enExample)
AU (1) AU2020271280B2 (enExample)
BR (1) BR112021020282A2 (enExample)
CA (1) CA3144742A1 (enExample)
DK (1) DK3952844T3 (enExample)
ES (1) ES3053040T3 (enExample)
IL (1) IL287121B1 (enExample)
PL (1) PL3952844T3 (enExample)
PT (1) PT3952844T (enExample)
WO (1) WO2020208202A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102024107712A1 (de) * 2024-03-18 2025-09-18 Glatt Gesellschaft Mit Beschränkter Haftung Vorrichtung zur Herstellung von Tabletten
DE102024107710A1 (de) * 2024-03-18 2025-09-18 Glatt Gesellschaft Mit Beschränkter Haftung Verfahren zur Herstellung von Tabletten

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2152212C1 (ru) 1994-01-14 2000-07-10 Лаборатуар Де Продюи Этик Этифарм Лекарственная форма производных 5-нитроимидазола
DE19514187C1 (de) * 1995-04-21 1996-05-15 Degussa Verfahren und Vorrichtung zur Herstellung von Granulaten durch Wirbelschicht-Sprühgranulation
DE59906894D1 (de) * 1998-07-21 2003-10-09 Vantico Ag Rieselfähige granulate
US6117451A (en) 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
DE10004939C1 (de) 2000-02-05 2001-08-23 Lothar Moerl Steuerbare Gasanströmeinrichtung für Strahlschichtapparate
KR20030074693A (ko) * 2000-12-28 2003-09-19 알투스 바이올로직스 인코포레이티드 전항체 및 이의 단편의 결정과 이의 제조 및 사용 방법
US6667054B2 (en) 2001-12-05 2003-12-23 Bernard Charles Sherman Metformin hydrochloride tablets
KR100592512B1 (ko) * 2002-11-22 2006-07-03 서울약품공업(주) 탐술로신 또는 약제학적으로 허용되는 이의 염을활성성분으로 하는 서방성 배뇨장애 치료제
DE10322062A1 (de) 2003-05-15 2004-12-02 Glatt Ingenieurtechnik Gmbh Verfahren und Vorrichtung zum Aufbringen von Flüssigkeiten in eine Feststoffströmung eines Strahlschichtapparates
CA2528637C (en) 2003-06-11 2012-10-23 Glatt Ingenieurtechnik Gmbh Method for production of enzyme granules and enzyme granules produced thus
DE102005037630A1 (de) * 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
DE102007012105A1 (de) * 2007-03-13 2008-09-18 Add Advanced Drug Delivery Technologies Ltd. Pellets enthaltend pharmazeutische Substanz, Verfahren zu deren Herstellung und deren Verwendung
WO2010066385A1 (de) 2008-12-08 2010-06-17 Ratiopharm Gmbh Kompaktiertes moxifloxacin
WO2010106555A2 (en) 2009-03-17 2010-09-23 Shantilal, Doshi, Bimalkumar Directly compressible pre-granulated cellulose ether polymer and process for preparing the same
WO2015012365A1 (ja) * 2013-07-25 2015-01-29 株式会社 三和化学研究所 医薬製剤
WO2018034627A1 (en) * 2016-08-18 2018-02-22 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Pharmaceutical composition of antidiabetic tablet
EP3721870A1 (de) * 2019-04-11 2020-10-14 ADD Advanced Drug Delivery Technologies, Ltd. Verfahren zur kontinuierlichen herstellung eines wirkstoffgranulats

Similar Documents

Publication Publication Date Title
JP2023012518A (ja) 増強された特性を有する粉末を生産するための改良噴霧乾燥方法
CN1582144A (zh) 制备干提取物的方法
JP2022528570A5 (enExample)
CN1222277C (zh) 基于活性成分的微颗粒及其制造方法
JP2022528783A5 (enExample)
WO2009002046A2 (en) Method for preparing ginseng concentrate pellets without excipient
Pachuau et al. A study on the effects of different surfactants on Ethylcellulose microspheres
US20260114496A1 (en) Nicotine-containing agglomerates and methods of forming the same
Rita Patrizia et al. Nanospray drying as a novel technique for the manufacturing of inhalable NSAID powders
CN108463213A (zh) 可吸入扎鲁司特颗粒的制备
CN110050793A (zh) 丙硫菌唑干悬浮剂、其制备方法及应用
JPH04159217A (ja) 徐放性製剤およびその製造方法
JP5358948B2 (ja) 粉末の被覆方法
EP0946149B1 (de) Homogene, steroide in hoher konzentration enthaltende, präformulierungen zur herstellung niedrigdosierter fester und halbfester pharmazeutischer zubereitungen
RU2021132567A (ru) Способ непрерывного изготовления гранулированного препарата активного ингредиента
Wan et al. Effect of polyvinylpyrrolidone solutions containing dissolved drug on characteristics of lactose fluidized bed granules
RU2021132568A (ru) Способ непрерывного изготовления гранулированного препарата активного ингредиента
CN1329016C (zh) 生药成分制剂的造粒方法
Sahoo et al. Effect of processing temperature on Eudragit RS PO microsphere characteristics in the solvent evaporation process
JP4332562B2 (ja) 製剤用核剤
JP2005502729A (ja) 植物抽出物から錠剤を製造するための方法
JP2008518942A (ja) 粒子の顆粒化方法
Patel et al. Formulation and Evaluation of Co-Processed MCC Core Pellets and Confirm Its Application in Layer-ing of Drugs with Different Solubility
WO2016155682A1 (en) A new step in the process of coating pellets containing tamsulosin.hci
JP2007502792A5 (enExample)